The Recall Desk
ModerateFDA (Devices)·Z-0436-2022·Announced 2022-01-05

VIDAS Lyme IgM II Diagnostic Test Kits Recalled for Substrate Error

bioMerieux is recalling three lots of VIDAS Lyme IgM II diagnostic test kits due to a substrate error that prevents the test from running, requiring users to conduct another test to obtain results.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: This is an FDA Class II medical device recall for a substrate defect that prevents test execution rather than producing incorrect results. With no evidence of misdiagnosis or patient harm, and the defect being immediately apparent to users, this precautionary recall meets the criteria for Moderate severity.

Plain-English summary

bioMerieux, Inc. is recalling three lots of VIDAS Lyme IgM II (LYM) diagnostic test kits (Lot numbers 1008636750, 1008768920, 1008857410) due to a substrate error discovered in the test kits.

A substrate error in the affected kits prevents the test from being completed. When this error occurs, users cannot complete the test and must conduct another test to obtain results, creating a delay in test turnaround time.

The affected test kits were distributed nationwide throughout the United States. Healthcare providers, laboratories, and other users with test kits from the affected lot numbers should stop using these kits and contact bioMerieux for instructions on replacement kits and further guidance.

The recalled product

Product
VIDAS Lyme IgM II (LYM), REF 416436
Manufacturer
bioMerieux, Inc.
Hazard
  • substrate-defect
  • test-failure

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (4)

  • UDI 03573026447151
  • Lot #: 1008636750
  • 1008768920
  • 1008857410

Distribution

Distributed nationwide across the United States.